Barry Hassett - 01 Nov 2026 Form 4 Insider Report for BioStem Technologies, Inc. (BSEM)

SEC form
4
Accepted by SEC
03 Nov 2026, 16:30:09 UTC
Prior SEC filing
11 Sep 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Barry Hassett filed Form 4 for BioStem Technologies, Inc. (BSEM) on 03 Nov 2026.

Key facts

  • This page summarizes Barry Hassett's Form 4 filing for BioStem Technologies, Inc. (BSEM).
  • 2 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 03 Nov 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 11 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147293 Primary reporting owner

HASSETT BARRY

Relationship
Chief Commercial Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSEM transaction

Common Stock

Options Exercise

Transaction value
Shares
+253
Change %
+5.1%
Price
$0.000000*
Shares after
5,256
Date
01 Nov 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSEM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-253
Change %
-17%
Price
$0.000000*
Shares after
1,266
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
253
Exercise price
Footnotes
F4, F6
BSEM holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,417
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,417
Exercise price
$14.89
Footnotes
F1
BSEM holding Derivative

Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,427
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,427
Exercise price
$14.89
Footnotes
F2
BSEM holding Derivative

Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
70,485
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
70,485
Exercise price
$5.50
Footnotes
F3
BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,497
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,497
Exercise price
Footnotes
F4, F5
BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
58,182
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
58,182
Exercise price
Footnotes
F4, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

These options vest according to the following schedule: 33% vested on February 1, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F2

These options vest according to the following schedule: 33%% vested on October 13, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F3

These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Footnote F5

These restricted stock units vest in equal quarterly installments over four years from the grant date (December 9, 2024).

Footnote F6

These restricted stock units vest according to the following schedule: 33% vested on February 1, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

Footnote F7

These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .